메뉴 건너뛰기




Volumn , Issue , 2010, Pages 19-58

PBPK Modeling: A Primer

Author keywords

ADME mathematical representation in PBPK models; Change rate in chemical amount in tissues proportional to concentration difference; Choosing in vitro test system; in silico methods, qualitative and quantitative structure activity relationship (QSAR) models for parameterizing PBPK models; Mixed venous blood concentration calculation in PBPK models; Model codes in QMT Model Library structured learning of PBPK modeling; PBPK model for Chloroprene; PBPK models, conceptual representations for selected chemicals; Pharmacokinetic models quantitative descriptions of time course behavior of chemicals in biological matrices; Physiologically based toxicokinetic and pharmacokinetic (PBPK) modeling

Indexed keywords


EID: 84886040028     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470686263.ch2     Document Type: Chapter
Times cited : (9)

References (50)
  • 1
    • 0027529301 scopus 로고
    • Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment
    • Andersen, M.E., Mills, J.J., and Gargas, M.L. (1993) Modeling receptor-mediated processes with dioxin: Implications for pharmacokinetics and risk assessment. Risk Anal., 13, 25-36.
    • (1993) Risk Anal. , vol.13 , pp. 25-36
    • Andersen, M.E.1    Mills, J.J.2    Gargas, M.L.3
  • 2
    • 33845996187 scopus 로고    scopus 로고
    • Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
    • Barter, Z.E., Bayliss, M.K., Beaune, P.H., et al. (2007) Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Current Drug Metabolism, 8 (1), 33-45.
    • (2007) Current Drug Metabolism , vol.8 , Issue.1 , pp. 33-45
    • Barter, Z.E.1    Bayliss, M.K.2    Beaune, P.H.3
  • 3
    • 18244379659 scopus 로고    scopus 로고
    • In silico approaches for developing physiologically based pharmacokinetic (PBPK) models
    • (eds H. Salem and S. Katz), CRC Press, NY
    • Béliveau, M. and Krishnan, K. (2003) In silico approaches for developing physiologically based pharmacokinetic (PBPK) models, in Alernative Toxicology Methods (eds H. Salem and S. Katz), CRC Press, NY, pp. 479-532.
    • (2003) in Alernative Toxicology Methods , pp. 479-532
    • Béliveau, M.1    Krishnan, K.2
  • 4
    • 18244382840 scopus 로고    scopus 로고
    • A spreadsheet program for modeling quantitative structurepharmacokinetic relationships for inhaled volatile organics in humans
    • Béliveau, M. and Krishnan, K. (2005) A spreadsheet program for modeling quantitative structurepharmacokinetic relationships for inhaled volatile organics in humans. SAR QSAR Environ. Res., 16, 63-77.
    • (2005) SAR QSAR Environ. Res. , vol.16 , pp. 63-77
    • Béliveau, M.1    Krishnan, K.2
  • 5
    • 15344349015 scopus 로고    scopus 로고
    • Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmaconkinetics of organic chemicals
    • Béliveau, M., Lipscomb, J., Tardif, R., and Krishnan, K. (2005) Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmaconkinetics of organic chemicals. Chem. Res. Toxicol., 18, 475-485.
    • (2005) Chem. Res. Toxicol. , vol.18 , pp. 475-485
    • Béliveau, M.1    Lipscomb, J.2    Tardif, R.3    Krishnan, K.4
  • 6
    • 0030806348 scopus 로고    scopus 로고
    • Physiological parameter values for physiologically based pharmacokinetic models
    • Brown, R.P., Delp, M.D., Lindstedt, S.L., et al. (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health, 13, 407-484.
    • (1997) Toxicol. Ind. Health , vol.13 , pp. 407-484
    • Brown, R.P.1    Delp, M.D.2    Lindstedt, S.L.3
  • 7
    • 34247510787 scopus 로고    scopus 로고
    • Evaluation of physiologically based pharmacokinetic models for use in risk assessment
    • Chiu, W.A., Barton, H.A., and Dewoskin, R.S. (2007) Evaluation of physiologically based pharmacokinetic models for use in risk assessment. Journal of Applied Toxicology, 27, 218-237.
    • (2007) Journal of Applied Toxicology , vol.27 , pp. 218-237
    • Chiu, W.A.1    Barton, H.A.2    Dewoskin, R.S.3
  • 8
    • 11344264355 scopus 로고    scopus 로고
    • Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment
    • Clark, L.H., Setzer,R.W., and Barton, H.A. (2004) Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment. Risk Anal., 24, 1697-1717.
    • (2004) Risk Anal. , vol.24 , pp. 1697-1717
    • Clark, L.H.1    Setzer, R.W.2    Barton, H.A.3
  • 9
    • 0036151312 scopus 로고    scopus 로고
    • A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment
    • Clewell, H.J., Andersen, M.E., and Barton, H.A. (2002) A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environmental Health Perspectives, 110, 85-93.
    • (2002) Environmental Health Perspectives , vol.110 , pp. 85-93
    • Clewell, H.J.1    Andersen, M.E.2    Barton, H.A.3
  • 10
    • 37549042390 scopus 로고    scopus 로고
    • Development and specification of physiologically based pharmacokinetic models for use in risk assessment
    • 3rd
    • Clewell, R.A., Clewell, H.J. 3rd (2008) Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regulatory Toxicology and Pharmacology, 50 (1), 129-143.
    • (2008) Regulatory Toxicology and Pharmacology , vol.50 , Issue.1 , pp. 129-143
    • Clewell, R.A.1    Clewell, H.J.2
  • 11
    • 0037452416 scopus 로고    scopus 로고
    • Atoxicokinetic model for styrene and its metabolite styrene-7,8-oxide in mouse, rat and human with special emphasis on the lung
    • Csanady, G.A., Kessler,W., Hoffmann H.D., and Filser, J.G. (2003)Atoxicokinetic model for styrene and its metabolite styrene-7,8-oxide in mouse, rat and human with special emphasis on the lung. Toxicol. Lett., 138, 75-102.
    • (2003) Toxicol. Lett. , vol.138 , pp. 75-102
    • Csanady, G.A.1    Kessler, W.2    Hoffmann, H.D.3    Filser, J.G.4
  • 12
    • 0030605039 scopus 로고    scopus 로고
    • A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts-relevance of glutathione depletion
    • Csanady, G.A., Kreuzer, P.E., Baur, C., and Filser, J.G. (1996) A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts-relevance of glutathione depletion. Toxicology, 113, 300-305.
    • (1996) Toxicology , vol.113 , pp. 300-305
    • Csanady, G.A.1    Kreuzer, P.E.2    Baur, C.3    Filser, J.G.4
  • 13
    • 0023916058 scopus 로고
    • Physiological model for tissue glutathione depletion and decreased resynthesis after ethylene dichloride exposures
    • D'Souza, R.W., Francis,W.R., and Andersen,M.W. (1988) Physiological model for tissue glutathione depletion and decreased resynthesis after ethylene dichloride exposures. J. Pharmacol. Exp. Ther., 245, 563-568.
    • (1988) J. Pharmacol. Exp. Ther. , vol.245 , pp. 563-568
    • D'Souza, R.W.1    Francis, W.R.2    Andersen, M.W.3
  • 14
    • 0012785645 scopus 로고
    • Mathematical modeling of inhalation exposure
    • Fiserova-Bergerova, V. (1975) Mathematical modeling of inhalation exposure. J. Combust. Toxicol., 32, 201-210.
    • (1975) J. Combust. Toxicol. , vol.32 , pp. 201-210
    • Fiserova-Bergerova, V.1
  • 16
    • 0029871040 scopus 로고    scopus 로고
    • A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares
    • Haddad, S., Pelekis, M., and Krishnan, K. (1996) A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares. Toxicol. Lett., 85, 113-126.
    • (1996) Toxicol. Lett. , vol.85 , pp. 113-126
    • Haddad, S.1    Pelekis, M.2    Krishnan, K.3
  • 18
    • 84885997477 scopus 로고
    • G. Fischer), VCH Publishers, Stuttgart/New York. Himmelstein,M.W., Carpenter, S.C., Evans,M.V., et al. (2004) Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis. Toxicol. Sci.
    • Heinzel, G.,Woloszczak, R., and Thomann, P. (1993) TopFit, Version 2.0: Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC (ed. G. Fischer), VCH Publishers, Stuttgart/New York. Himmelstein,M.W., Carpenter, S.C., Evans,M.V., et al. (2004) Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis. Toxicol. Sci., 79, 28-37.
    • (1993) TopFit, Version 2.0: Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC (ed , vol.79 , pp. 28-37
    • Heinzel, G.1    Woloszczak, R.2    Thomann, P.3
  • 19
    • 0028342648 scopus 로고
    • Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
    • Houston, J.B. (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol., 47, 1469-1479.
    • (1994) Biochem. Pharmacol. , vol.47 , pp. 1469-1479
    • Houston, J.B.1
  • 20
    • 0025666559 scopus 로고
    • Interspecies scaling and comparisons in drug development and toxicokinetics
    • Ings, R.M.J. (1990) Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica, 20, 1201-1231.
    • (1990) Xenobiotica , vol.20 , pp. 1201-1231
    • Ings, R.M.J.1
  • 21
    • 0035951611 scopus 로고    scopus 로고
    • Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene
    • Jonsson, F. and Johanson, G. (2001) Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene. Toxicology, 157, 177-193.
    • (2001) Toxicology , vol.157 , pp. 177-193
    • Jonsson, F.1    Johanson, G.2
  • 22
    • 57349189517 scopus 로고    scopus 로고
    • An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats
    • Kamgang, E., Peyret, T., and Krishnan, K. (2008) An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats. SAR QSAR Environ. Res., 19, 669-680.
    • (2008) SAR QSAR Environ. Res. , vol.19 , pp. 669-680
    • Kamgang, E.1    Peyret, T.2    Krishnan, K.3
  • 23
    • 44349129408 scopus 로고
    • The theory and application of the exchange of inert gas at the lungs
    • Kety, S.S. (1951) The theory and application of the exchange of inert gas at the lungs. Pharmacol. Rev., 3, 1-41.
    • (1951) Pharmacol. Rev. , vol.3 , pp. 1-41
    • Kety, S.S.1
  • 24
    • 0002252722 scopus 로고
    • Physiologically based pharmacokinetic modeling in toxicology
    • (ed. A.W. Hayes), Raven Press Ltd, New York
    • Krishnan, K. and Andersen, M.E. (1994) Physiologically based pharmacokinetic modeling in toxicology, in Principals and Methods of Toxicology (ed. A.W. Hayes), Raven Press Ltd., New York, pp. 149-188.
    • (1994) in Principals and Methods of Toxicology , pp. 149-188
    • Krishnan, K.1    Andersen, M.E.2
  • 25
    • 0000581605 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetic modeling in toxicology
    • (ed. A.W. Hayes), Taylor and Francis, Philadelphia, PA
    • Krishnan, K. and Andersen, M.E. (2001) Physiologically based pharmacokinetic modeling in toxicology, in Principles and Methods of Toxicology (ed. A.W. Hayes), Taylor & Francis, Philadelphia, PA, pp. 193-241.
    • (2001) in Principles and Methods of Toxicology , pp. 193-241
    • Krishnan, K.1    Andersen, M.E.2
  • 26
    • 0000581605 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetic modeling in toxicology
    • (ed. A.W. Hayes), Taylor and Francis, New York
    • Krishnan, K. and Andersen, M.E. (2007) Physiologically based pharmacokinetic modeling in toxicology, in Principles and Methods of Toxicology (ed. A.W. Hayes), Taylor & Francis, New York, pp. 193-241.
    • (2007) in Principles and Methods of Toxicology , pp. 193-241
    • Krishnan, K.1    Andersen, M.E.2
  • 27
    • 0026653651 scopus 로고
    • A physiologically-based description of ethylene oxide dosimetry in the rat
    • Krishnan, K., Gargas, M.L., Fennell, T.R., and Andersen, M.E. (1992) A physiologically-based description of ethylene oxide dosimetry in the rat. Toxicol. Ind. Health, 8, 121-140.
    • (1992) Toxicol. Ind. Health , vol.8 , pp. 121-140
    • Krishnan, K.1    Gargas, M.L.2    Fennell, T.R.3    Andersen, M.E.4
  • 28
    • 1042274085 scopus 로고    scopus 로고
    • Kluwer Academic/Plenum Publishers, New York Lipscomb, J.C. and Ohanian, E.V. (eds.) (2006) Toxicokinetics and Risk Assessment, Informa Healthcare, New York, NY, 361 pp. Lipscomb, J.C. and Poet, T.S. (2008) In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacology and Therapeutics
    • Kwon, Y. (2001) Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists, Kluwer Academic/Plenum Publishers, New York. Lipscomb, J.C. and Ohanian, E.V. (eds.) (2006) Toxicokinetics and Risk Assessment, Informa Healthcare, New York, NY, 361 pp. Lipscomb, J.C. and Poet, T.S. (2008) In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacology and Therapeutics, 118, 82-103.
    • (2001) Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists , vol.118 , pp. 82-103
    • Kwon, Y.1
  • 29
    • 0345791469 scopus 로고    scopus 로고
    • The Impact of Cytochrome P450 2E1- dependent Metabolic Variance on a Risk Relevant Pharmacokinetic Outcome in Humans
    • Lipscomb, J.C., Teuschler, L.K., Swartout, J., et al. (2003) The Impact of Cytochrome P450 2E1- dependent Metabolic Variance on a Risk Relevant Pharmacokinetic Outcome in Humans. Risk Analysis, 23, 1221-1238.
    • (2003) Risk Analysis , vol.23 , pp. 1221-1238
    • Lipscomb, J.C.1    Teuschler, L.K.2    Swartout, J.3
  • 30
    • 1642523389 scopus 로고    scopus 로고
    • The metabolic rate constants and specific activity of human and rat cytochrome P450 2E1 toward chloroform
    • Lipscomb, J.C., Barton, H., Tornero-Velez, R., et al. (2004) The metabolic rate constants and specific activity of human and rat cytochrome P450 2E1 toward chloroform. J. Toxicol. Envtl. Hlth. (Part A), 67, 537-553.
    • (2004) J. Toxicol. Envtl. Hlth. (Part A) , vol.67 , pp. 537-553
    • Lipscomb, J.C.1    Barton, H.2    Tornero-Velez, R.3
  • 31
    • 33750183365 scopus 로고    scopus 로고
    • An integrated approach to model hepatic drug clearance
    • Liu, L. and Pang, K.S. (2006) An integrated approach to model hepatic drug clearance. Eur. J. Pharm. Sci., 29, 215-230.
    • (2006) Eur. J. Pharm. Sci. , vol.29 , pp. 215-230
    • Liu, L.1    Pang, K.S.2
  • 32
    • 0001015241 scopus 로고
    • An electric analog for uptake and elimination in man
    • Mapleson, W.W. (1963) An electric analog for uptake and elimination in man. J. Appl. Physiol., 18, 197-204.
    • (1963) J. Appl. Physiol. , vol.18 , pp. 197-204
    • Mapleson, W.W.1
  • 33
    • 34250639000 scopus 로고    scopus 로고
    • In vitro metabolism of the fungicide and environmental contaminant trans-bromuconazole and implications for risk assessment
    • Mazur, C.S., Kenneke, J.F., Tebes-Stevens, C., et al. (2007) In vitro metabolism of the fungicide and environmental contaminant trans-bromuconazole and implications for risk assessment. J. Toxicol. Envtl. Health, 70, 1241-1250.
    • (2007) J. Toxicol. Envtl. Health , vol.70 , pp. 1241-1250
    • Mazur, C.S.1    Kenneke, J.F.2    Tebes-Stevens, C.3
  • 34
    • 84886052279 scopus 로고
    • Poulin, P. and Krishnan, K. (1995) An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data. J. Toxicol. Environ. Health
    • Notari, R.E. (1987) Biopharmaceutics and Clinical Pharmacokinetics: An Introduction, Marcel Dekker, New York. Poulin, P. and Krishnan, K. (1995) An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data. J. Toxicol. Environ. Health, 46, 117-129.
    • (1987) Biopharmaceutics and Clinical Pharmacokinetics: An Introduction, Marcel Dekker, New York , vol.46 , pp. 117-129
    • Notari, R.E.1
  • 35
    • 0033966128 scopus 로고    scopus 로고
    • A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery
    • Poulin, P. and Theil, F.P. (2000) A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J. Pharm. Sci., 89, 16-35.
    • (2000) J. Pharm. Sci. , vol.89 , pp. 16-35
    • Poulin, P.1    Theil, F.P.2
  • 36
    • 0036144815 scopus 로고    scopus 로고
    • Prediction of pharmacokinetics prior to in vivo studies 1.Mechanismbased prediction of volume of distribution
    • Poulin, P. and Theil, F.P. (2002) Prediction of pharmacokinetics prior to in vivo studies. 1.Mechanismbased prediction of volume of distribution. J. Pharm. Sci., 91, 129-156.
    • (2002) J. Pharm. Sci. , vol.91 , pp. 129-156
    • Poulin, P.1    Theil, F.P.2
  • 37
    • 0000900027 scopus 로고    scopus 로고
    • Mechanistic animal replacement approaches for predicting pharmacokinetics of organic chemicals
    • (eds H. Salem and S.A. Katz), Humana Press Inc., Totowa, NJ
    • Poulin, P., Beliveau, M., and Krishnan, K. (1999) Mechanistic animal replacement approaches for predicting pharmacokinetics of organic chemicals, in Toxicity Assessment alternatives: Methods, Issues, Opportunities (eds H. Salem and S.A. Katz), Humana Press Inc., Totowa, NJ, pp. 115- 139.
    • (1999) in Toxicity Assessment alternatives: Methods, Issues, Opportunities , pp. 115-139
    • Poulin, P.1    Beliveau, M.2    Krishnan, K.3
  • 38
    • 0021279862 scopus 로고
    • A physiologically-based description of the inhalation pharmacokinetics of styrene in rats and humans
    • Ramsey, J.C. and Andersen, M.E. (1984) A physiologically-based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol., 73, 159-175.
    • (1984) Toxicol. Appl. Pharmacol. , vol.73 , pp. 159-175
    • Ramsey, J.C.1    Andersen, M.E.2
  • 40
    • 0027242397 scopus 로고
    • Validation and use of cloned, expressed human drugmetabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions
    • Remmel, R.P. and Burchell, B. (1993) Validation and use of cloned, expressed human drugmetabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions. Biochem. Pharmacol., 46, 559-566.
    • (1993) Biochem. Pharmacol. , vol.46 , pp. 559-566
    • Remmel, R.P.1    Burchell, B.2
  • 43
    • 21344469211 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases
    • Rodgers, T., Leahy, D., and Rowland, M. (2005) Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J. Pharm. Sci., 94, 1259-1276.
    • (2005) J. Pharm. Sci. , vol.94 , pp. 1259-1276
    • Rodgers, T.1    Leahy, D.2    Rowland, M.3
  • 44
    • 33745055239 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
    • Rodgers, T. and Rowland, M. (2006) Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J. Pharm. Sci., 95, 1238-1257.
    • (2006) J. Pharm. Sci. , vol.95 , pp. 1238-1257
    • Rodgers, T.1    Rowland, M.2
  • 46
    • 0028237729 scopus 로고
    • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japaneses and 30 Caucasions
    • Shimada, T., Yamazaki, H., Mimura, M., et al. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japaneses and 30 Caucasions. J. Pharmacol. Exp. Ther., 270, 414-423.
    • (1994) J. Pharmacol. Exp. Ther. , vol.270 , pp. 414-423
    • Shimada, T.1    Yamazaki, H.2    Mimura, M.3
  • 47
    • 0033743267 scopus 로고    scopus 로고
    • Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment
    • Snawder, J.E. and Lipscomb, J.C. (2000) Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment. Regul. Toxicol. Pharmacol., 32, 200-209.
    • (2000) Regul. Toxicol. Pharmacol. , vol.32 , pp. 200-209
    • Snawder, J.E.1    Lipscomb, J.C.2
  • 48
    • 0001146538 scopus 로고
    • Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration
    • Teorell, T. (1937a)Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration. Arch. Int. Pharmacodyn., 57, 205-225.
    • (1937) Arch. Int. Pharmacodyn , vol.57 , pp. 205-225
    • Teorell, T.1
  • 49
    • 0001146538 scopus 로고
    • Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration
    • Teorell, T. (1937b) Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration. Arch. Int. Pharmacodyn., 57, 226-240.
    • (1937) Arch. Int. Pharmacodyn , vol.57 , pp. 226-240
    • Teorell, T.1
  • 50
    • 84885964591 scopus 로고    scopus 로고
    • USEPA (United States Environmental Protection Agency) (2005) Use of Physiologically Based Pharmacokinetic Models to Quantify the Impact of Human Age and Interindividual Differences in Physiology and Biochemistry Pertinent to Risk: Final Report for Cooperative Agreement. EPA 600/R-06-014A. USEPA (United States Environmental Protection Agency) Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. EPA 600/R-05/043A.
    • USEPA (United States Environmental Protection Agency) (2005) Use of Physiologically Based Pharmacokinetic Models to Quantify the Impact of Human Age and Interindividual Differences in Physiology and Biochemistry Pertinent to Risk: Final Report for Cooperative Agreement. EPA 600/R-06-014A. USEPA (United States Environmental Protection Agency) (2006) Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. EPA 600/R-05/043A.
    • (2006)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.